FIRST DO NO HARM Trademark

Trademark Overview


On Wednesday, October 3, 2001, a trademark application was filed for FIRST DO NO HARM with the United States Patent and Trademark Office. The USPTO has given the FIRST DO NO HARM trademark a serial number of 76320907. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Friday, November 29, 2002. This trademark is owned by EPIGENESIS Pharmaceuticals, Inc.. The FIRST DO NO HARM trademark is filed in the Pharmaceutical Products category with the following description:

describing aerosolized pharmaceutical preparations and delivery devices for an aerosolized or sprayed salt solution, such as a sodium chloride solution, of particle size up to about 10 micron, for administration via respiratory airways for treatment of respiratory, airway and pulmonary diseases and conditions, such as airway dryness, airway dehydration, asthma and associated symptoms including bronchoconstriction, difficult breathing, wheezing, pulmonary vasoconstriction, allergic rhinitis, allergic bronchitis, pulmonary hypertension, pulmonary vasoconstriction, impeded or obstructed lung airways, respiratory tract allergies and inflammation, more particularly for use in testing, diagnostic, preventive and therapeutic applications included
first do no harm

General Information


Serial Number76320907
Word MarkFIRST DO NO HARM
Filing DateWednesday, October 3, 2001
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateFriday, November 29, 2002
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 5, 2002

Trademark Statements


Goods and Servicesdescribing aerosolized pharmaceutical preparations and delivery devices for an aerosolized or sprayed salt solution, such as a sodium chloride solution, of particle size up to about 10 micron, for administration via respiratory airways for treatment of respiratory, airway and pulmonary diseases and conditions, such as airway dryness, airway dehydration, asthma and associated symptoms including bronchoconstriction, difficult breathing, wheezing, pulmonary vasoconstriction, allergic rhinitis, allergic bronchitis, pulmonary hypertension, pulmonary vasoconstriction, impeded or obstructed lung airways, respiratory tract allergies and inflammation, more particularly for use in testing, diagnostic, preventive and therapeutic applications included

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 17, 2001
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEPIGENESIS Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCranbury, NJ 08512

Party NameEPIGENESIS Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCranbury, NJ 08512

Trademark Events


Event DateEvent Description
Saturday, February 22, 2003ABANDONMENT - NO USE STATEMENT FILED
Tuesday, May 28, 2002NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 5, 2002PUBLISHED FOR OPPOSITION
Wednesday, February 13, 2002NOTICE OF PUBLICATION
Wednesday, December 12, 2001APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 11, 2001ASSIGNED TO EXAMINER